Create a narrative

Catalyst Pharmaceuticals Community

NasdaqCM:CPRX Community

1 Narratives written by author
0 Comments on narratives written by author
83 Fair Values set on narratives written by author

Create a narrative

Catalyst Pharmaceuticals

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 7 Analysts

Global Expansion And Patent Protection Will Secure Future Profitability

Key Takeaways Successful launch of AGAMREE and strong FIRDAPSE performance are set to boost revenue and margins, enhancing earnings potential. Patent protection, international expansion, and strategic investments will strengthen competitive position, diversify the portfolio, and support long-term growth.

US$36.80

FV

43.2% undervalued

11.47%

Revenue growth p.a.

1

0

38

7 days ago